{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":2,"total":109,"mapped":2},"pagination":{"has_next":true,"next_token":"-1[]P37231,1,P37231,177,3]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P37231","source":"P37231|Peroxisome proliferator-activated receptor gamma","targets":["1FM6|THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1FM9|THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1I7I|CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242|X-RAY DIFFRACTION|2.35|Homo sapiens|0|TRANSCRIPTION","1K74|The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides.|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","1KNU|LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST|X-RAY DIFFRACTION|2.5|Homo sapiens|0|DNA BINDING PROTEIN","1NYX|Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSCRIPTION","1PRG|LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA|X-RAY DIFFRACTION|2.2|Homo sapiens|0|GENE REGULATION","1RDT|Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|HORMONE/GROWTH FACTOR","1WM0|PPARgamma in complex with a 2-BABA compound|X-RAY DIFFRACTION|2.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/SIGNALING PROTEIN","1ZEO|Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSCRIPTION","1ZGY|Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP|X-RAY DIFFRACTION|1.8|Homo sapiens; Rattus norvegicus|0|TRANSCRIPTION","2ATH|Crystal structure of the ligand binding domain of human PPAR-gamma im complex with an agonist|X-RAY DIFFRACTION|2.28|Homo sapiens|0|TRANSCRIPTION","2F4B|Crystal structure of the ligand binding domain of human PPAR-gamma in complex with an agonist|X-RAY DIFFRACTION|2.07|Homo sapiens|0|TRANSCRIPTION ACTIVATOR","2FVJ|A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro|X-RAY DIFFRACTION|1.99|Homo sapiens|0|SIGNALING PROTEIN","2G0G|Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities|X-RAY DIFFRACTION|2.54|Homo sapiens|0|TRANSCRIPTION ACTIVATOR","2G0H|Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION ACTIVATOR","2GTK|Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION REGULATOR","2HFP|Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","2HWQ|Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists|X-RAY DIFFRACTION|1.97|Homo sapiens|0|LIGAND BINDING PROTEIN","2HWR|Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists|X-RAY DIFFRACTION|2.34|Homo sapiens|0|LIGAND BINDING PROTEIN","2I4J|Crystal structure of the complex between PPARgamma and the agonist LT160 (ureidofibrate derivative)|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","2I4P|Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). Structure obtained from crystals of the apo-form soaked for 30 days.|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","2I4Z|Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). This structure has been obtained from crystals soaked for 6 hours.|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSCRIPTION","2OM9|Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSCRIPTION","2P4Y|Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSCRIPTION","2POB|PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709|X-RAY DIFFRACTION|2.3|Homo sapiens|0|GENE REGULATION","2PRG|LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA|X-RAY DIFFRACTION|2.3|Homo sapiens|0|COMPLEX (THIAZOLIDINEDIONE/RECEPTOR)","2Q59|Crystal Structure of PPARgamma LBD bound to full agonist MRL20|X-RAY DIFFRACTION|2.2|Homo sapiens|0|Ligand binding protein","2Q5P|Crystal Structure of PPARgamma bound to partial agonist MRL24|X-RAY DIFFRACTION|2.3|Homo sapiens|0|Ligand binding protein","2Q5S|Crystal Structure of PPARgamma bound to partial agonist nTZDpa|X-RAY DIFFRACTION|2.05|Homo sapiens|0|Ligand binding protein","2Q61|Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145|X-RAY DIFFRACTION|2.197|Homo sapiens|0|Ligand binding protein","2Q6R|Crystal structure of PPAR gamma complexed with partial agonist SF147|X-RAY DIFFRACTION|2.407|Homo sapiens|0|Ligand binding protein","2Q6S|2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides|X-RAY DIFFRACTION|2.4|Homo sapiens|0|Ligand binding protein","2Q8S|X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist|X-RAY DIFFRACTION|2.3|Homo sapiens|0|hormone receptor","2QMV|High Resolution Structure of Peroxisone Proliferation-Activated Receptor gamma and Characterisation of its Interaction with the Co-activator Transcriptional Intermediary Factor 2|SOLUTION NMR||Homo sapiens|0|transcription regulator","2VSR|hPPARgamma Ligand binding domain in complex with 9-(S)-HODE|X-RAY DIFFRACTION|2.05|HOMO SAPIENS|0|RECEPTOR","2VST|hPPARgamma Ligand binding domain in complex with 13-(S)-HODE|X-RAY DIFFRACTION|2.35|HOMO SAPIENS|0|RECEPTOR","2VV0|hPPARgamma Ligand binding domain in complex with DHA|X-RAY DIFFRACTION|2.55|HOMO SAPIENS|0|RECEPTOR","2VV1|hPPARgamma Ligand binding domain in complex with 4-HDHA|X-RAY DIFFRACTION|2.2|HOMO SAPIENS|0|RECEPTOR","2VV2|hPPARgamma Ligand binding domain in complex with 5-HEPA|X-RAY DIFFRACTION|2.75|HOMO SAPIENS|0|RECEPTOR","2VV3|hPPARgamma Ligand binding domain in complex with 4-oxoDHA|X-RAY DIFFRACTION|2.85|HOMO SAPIENS|0|RECEPTOR","2VV4|hPPARgamma Ligand binding domain in complex with 6-oxoOTE|X-RAY DIFFRACTION|2.35|HOMO SAPIENS|0|RECEPTOR","2XKW|LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE|X-RAY DIFFRACTION|2.02|HOMO SAPIENS|0|TRANSCRIPTION","2YFE|Ligand binding domain of human PPAR gamma in complex with amorfrutin 1|X-RAY DIFFRACTION|2|HOMO SAPIENS|0|RECEPTOR","2ZK0|Human peroxisome proliferator-activated receptor gamma ligand binding domain|X-RAY DIFFRACTION|2.36|Homo sapiens|0|TRANSCRIPTION","2ZK1|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2|X-RAY DIFFRACTION|2.61|Homo sapiens|0|TRANSCRIPTION","2ZK2|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin J2|X-RAY DIFFRACTION|2.26|Homo sapiens|0|TRANSCRIPTION","2ZK3|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid|X-RAY DIFFRACTION|2.58|Homo sapiens|0|TRANSCRIPTION","2ZK4|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid|X-RAY DIFFRACTION|2.57|Homo sapiens|0|TRANSCRIPTION","2ZK5|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233|X-RAY DIFFRACTION|2.45|Homo sapiens|0|TRANSCRIPTION","2ZK6|Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with C8-BODIPY|X-RAY DIFFRACTION|2.41|Homo sapiens|0|TRANSCRIPTION","2ZNO|Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","2ZVT|Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSCRIPTION","3ADS|Human PPARgamma ligand-binding domain in complex with indomethacin|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSCRIPTION","3ADT|Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSCRIPTION","3ADU|Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate|X-RAY DIFFRACTION|2.77|Homo sapiens|0|TRANSCRIPTION","3ADV|Human PPARgamma ligand-binding domain in complex with serotonin|X-RAY DIFFRACTION|2.27|Homo sapiens|0|TRANSCRIPTION","3ADW|Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid|X-RAY DIFFRACTION|2.07|Homo sapiens|0|TRANSCRIPTION","3ADX|Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSCRIPTION","3AN3|Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3AN4|Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3B0Q|Human PPAR gamma ligand binding domain in complex with MCC555|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","3B0R|Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form|X-RAY DIFFRACTION|2.15|Homo sapiens|0|TRANSCRIPTION","3B1M|Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator Cerco-A|X-RAY DIFFRACTION|1.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3B3K|Crystal structure of the complex between PPARgamma and the full agonist LT175|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSCRIPTION","3BC5|X-ray crystal structure of human ppar gamma with 2-(5-(3-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2-phenyl-2h-1,2,3-triazol-4-yl)acetic acid|X-RAY DIFFRACTION|2.27|Homo sapiens|0|TRANSCRIPTION","3CDP|Crystal structure of PPAR-gamma LBD complexed with a partial agonist, analogue of clofibric acid|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSCRIPTION","3CDS|Crystal structure of the complex between PPAR-gamma and the agonist LT248 (clofibric acid analogue)|X-RAY DIFFRACTION|2.65|Homo sapiens|0|TRANSCRIPTION","3CS8|Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|NUCLEAR PROTEIN","3CWD|Molecular recognition of nitro-fatty acids by PPAR gamma|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3D6D|Crystal Structure of the complex between PPARgamma LBD and the LT175(R-enantiomer)|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","3DZU|Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic Acid and NCOA2 Peptide|X-RAY DIFFRACTION|3.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transcription/DNA","3DZY|Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide|X-RAY DIFFRACTION|3.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transcription/DNA","3E00|Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic Acid and NCOA2 Peptide|X-RAY DIFFRACTION|3.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transcription/DNA","3ET0|Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSCRIPTION","3ET3|Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSCRIPTION","3FEJ|Design and biological evaluation of novel, balanced dual PPARa/g agonists|X-RAY DIFFRACTION|2.01|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3FUR|Crystal Structure of PPARg in complex with INT131|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/Transcription regulator","3G9E|Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/TRANSFERASE","3GBK|Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with a Potent and Selective Agonist|X-RAY DIFFRACTION|2.3|Homo sapiens|0|ligand binding protein","3H0A|Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3HO0|Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSCRIPTION","3HOD|Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSCRIPTION","3IA6|X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist|X-RAY DIFFRACTION|2.31|Homo sapiens|0|TRANSCRIPTION","3K8S|Crystal Structure of PPARg in complex with T2384|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSCRIPTION","3KMG|The X-ray Crystal Structure of PPAR-gamma in Complex with an Indole Derivative Modulator, GSK538, and an SRC-1 Peptide|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3LMP|Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator|X-RAY DIFFRACTION|1.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3NOA|Crystal structure of human PPAR-gamma ligand binding domain complex with a potency improved agonist|X-RAY DIFFRACTION|1.98|Homo sapiens|0|TRANSCRIPTION","3OSI|Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA)|X-RAY DIFFRACTION|2.7|Homo sapiens|0|TRANSCRIPTION","3OSW|Crystal structure of PPARgamma ligand binding domain in complex with tetrabromo-bisphenol A (TBBPA)|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSCRIPTION","3PBA|Crystal structure of PPARgamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol A (MonoTBBPA)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3PO9|Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin|X-RAY DIFFRACTION|2.35|Homo sapiens|0|TRANSCRIPTION","3PRG|LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR|X-RAY DIFFRACTION|2.9|Homo sapiens|0|NUCLEAR RECEPTOR","3QT0|Revealing a steroid receptor ligand as a unique PPARgamma agonist|X-RAY DIFFRACTION|2.496|Homo sapiens|0|TRANSCRIPTION","3R5N|Crystal structure of PPARgammaLBD complexed with the agonist magnolol|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSCRIPTION/TRANSCRIPTION AGONIST","3R8A|X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity|X-RAY DIFFRACTION|2.41|Homo sapiens|0|NUCLEAR PROTEIN","3R8I|Crystal Structure of PPARgamma with an achiral ureidofibrate derivative (RT86)|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3S9S|Ligand binding domain of PPARgamma complexed with a benzimidazole partial agonist|X-RAY DIFFRACTION|2.55|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","3SZ1|Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","3T03|Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION/TRANSCRIPTION REGULATOR"]},{"input":"Q14654","source":"Q14654|ATP-sensitive inward rectifier potassium channel 11","targets":["6C3O|Cryo-EM structure of human KATP bound to ATP and ADP in quatrefoil form|ELECTRON MICROSCOPY|3.9|Homo sapiens|0|TRANSPORT PROTEIN","6C3P|Cryo-EM structure of human KATP bound to ATP and ADP in propeller form|ELECTRON MICROSCOPY|5.6|Homo sapiens|0|TRANSPORT PROTEIN","7S5T|Human KATP channel in open conformation, focused on Kir (C166S G334D double mutant) and SUR TMD0|ELECTRON MICROSCOPY|3.1|Homo sapiens|0|MEMBRANE PROTEIN","7S5X|Human KATP channel in open conformation, focused on Kir and one SUR, position 1|ELECTRON MICROSCOPY|3.7|Homo sapiens|0|MEMBRANE PROTEIN","7S5Y|Human KATP channel in open conformation, focused on Kir and one SUR, position 2|ELECTRON MICROSCOPY|3.9|Homo sapiens|0|MEMBRANE PROTEIN","7S5Z|Human KATP channel in open conformation, focused on Kir and one SUR, position 3|ELECTRON MICROSCOPY|3.9|Homo sapiens|0|MEMBRANE PROTEIN","7S60|Human KATP channel in open conformation, focused on Kir and one SUR, position 4|ELECTRON MICROSCOPY|3.7|Homo sapiens|0|MEMBRANE PROTEIN","7S61|Human KATP channel in open conformation, focused on Kir and one SUR, position 5|ELECTRON MICROSCOPY|4.0|Homo sapiens|0|MEMBRANE PROTEIN","9KGL|Structure of KATP channel in complex with centipede toxin SpTx1|ELECTRON MICROSCOPY|2.88|Homo sapiens; Mesocricetus auratus; Scolopendra polymorpha|0|TRANSPORT PROTEIN"]}]}